US 2003/0212009 A1 · Isoflavone derivatives

Abstract

Isoflavones are modified by esterification at one or more of the C4′, C5, C6, and C7 positions to promote bioavailability, and especially to enhance solubility over the corresponding unesterified isoflavones. Preferred modifications produce a carboxylic acid hemiester or a phosphate ester which is biologically hydrolysable. Preferred starting isoflavones are genistin and daidzin, and still more preferably comprises an aglycone form such as genistein or daidzein. Esterified isoflavones may be employed therapeutically or prophylactically for a variety of conditions, provided as a dietary supplement, or added to natural or processed food-stuffs. Further preferred uses include incorporation of contemplated compounds into topical formulations, and especially cosmetic topical formulations.

Claims8

Dependent claims

A method of providing skin care products, comprising:

providing a topical formulation that includes a compound having the structure:
3
wherein R8, R7, R6, R5 and R4′ are independently selected from the group consisting of H, OH, OMe, glucose, O-glucose, O-acetyl glucose, O-malonyl glucose, ZCOO— and ZPO4—;
and
with the proviso that at least one of R8, R7, R6, R5 and R4′ is ZCOO— or ZPO4—, where Z is selected from the group consisting of hydrogen, a straight or branched alkyl, alkenyl, alkynyl, alkoxyalkyl, alkylthioalkyl, or aminoalkyl, a substituted or non-substituted cycloalkyl, an aryl, aralkyl, or alkylaryl, and a substituted cycloalkyl where at least one ring contains one or more of a nitrogen, sulfur, oxygen, phosphorous or silicon heteroatom in the at least one ring.

2 more elements

Dependencies are inferred from the claim text.

Isoflavone derivatives

Life of this patent

Isoflavone derivatives

Life of this patent

Abstract

Claims8